Search clinical trials for: Optimal duration of clopidogrel post DES stent implantation

Total 475185 results

North Texas Veterans Healthcare System

Completed

Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial) (SCORE)

Myocardial Infarction

United States, Greece, India
Assistance Publique - Hôpitaux de Paris
Fédération Française de Cardiologie

Completed

Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation (OPTIDUAL)

Myocardial Ischemia | Coronary Artery Disease | Stent Thrombosis

France
Samsung Medical Center
Medtronic

Completed

The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent (DATE)

Coronary Artery Disease

Korea, Republic of
Seoul National University Bundang Hospital
Seoul St. Mary's Hospital; Asan Medical Center; Seoul National University Hospital and other collaborators

Recruiting

Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling

Endovascular Procedures | Aneurysm Cerebral

Korea, Republic of
Samsung Medical Center

Recruiting

CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4 (SMART-CHOICE4)

Coronary Artery Disease

Korea, Republic of
Joo-Yong Hahn

Recruiting

SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3 (SMART-CHOICE3)

Coronary Artery Disease

Korea, Republic of
DongGuk University
Pusan National University Hospital; Seoul National University Hospital; Gachon... and other collaborators

Active, not recruiting

Optimal Placement Duration of Pancreatic Duct Stent

Cholangitis | Post-ERCP Acute Pancreatitis | Stent Dislodgement

Korea, Republic of
Federico II University
AdvicePharma Group

Active, not recruiting

Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES (PARTHENOPE)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Chronic Coronary Syndrome

Italy
Seung-Jung Park
CardioVascular Research Foundation, Korea

Active, not recruiting

Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events (BVS LATE)

Coronary Disease | Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
Abbott Medical Devices
Abbott

Completed

ILUMIEN IV: OPTIMAL PCI

Coronary Artery Disease | Atherosclerosis | Coronary Stenosis | STEMI | NSTEMI - Non-ST Segment Elevation MI | STEMI - ST Elevation Myocardial Infarction

United States, Spain, Australia, United Kingdom, Canada, New Zealand, Denmark, Switzerland, Germany, Netherlands, India, Japan, Italy, Belgium, France, Hong Kong, Portugal, Singapore, Sweden, Taiwan
The First Affiliated Hospital with Nanjing Medical...
National Natural Science Foundation of China

Completed

OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial (OPTIMA-2)

Coronary Artery Disease

China
Gangnam Severance Hospital

Completed

Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents (OPTIMA-C)

Ischemic Heart Disease
Associations for Establishment of Evidence in Interventions
Medtronic

Completed

Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients (OPERA)

Coronary Artery Disease

Japan
Genoss Co., Ltd.

Recruiting

Evaluating Efficacy and Safety of Short Duration of DAPT After Genoss DES Stent Implantation in Patients (DAPTShort)

Acute Coronary Syndrome | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy

Korea, Republic of
Institute of Cardiology, Warsaw, Poland
Medical Research Agency, Poland

Recruiting

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients (SAFE LAAC CKD)

Atrial Fibrillation

Poland
Yonsei University

Recruiting

Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

Ischemic Heart Disease

Korea, Republic of
Lepu Medical Technology (Beijing) Co., Ltd.

Not yet recruiting

Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

Coronary Heart Disease

China
Yonsei University

Not yet recruiting

24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial

High Ischemic Risk

Korea, Republic of
John Paul II Hospital, Krakow

Recruiting

Simultaneous Cardiac Surgery and Micronet-covered Stent Carotid Revascularization in High Perioperative Stroke Risk Patients (SIM-GUARD)

Myocardial Infarction | Coronary Artery Disease | Carotid Stenosis | Valvular Heart Disease | Pulmonary Edema With Heart Failure

Poland
CCRF Inc., Beijing, China
BSC International Medical Trading (Shanghai) Co., Ltd.

Recruiting

To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease. (CRUISE-CTO)

Chronic Total Occlusion of Coronary Artery

China
Yale University
Boston Scientific Corporation

Recruiting

Optimal Duration of Post-Operative Activity Restriction After Midurethral Sling Procedures

Urinary Stress Incontinence

United States
Yonsei University

Recruiting

Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

Atrial Fibrillation

Korea, Republic of
John Paul II Hospital, Krakow
InspireMD

Recruiting

OPTIMAl Endovascular Exclusion of Consecutive Patient High-risk Carotid Plaque Using the MicroNet Covered Stent (OPTIMA)

Carotid Artery Diseases

Poland
National Institute of Cardiology, Warsaw, Poland
Medical Research Agency, Poland

Recruiting

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure (SAFE-LAAC)

Atrial Fibrillation

Poland
Vinay Badhwar

Enrolling by invitation

Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL) (OPTIMAL)

Endocarditis

United States
Yonsei University

Active, not recruiting

A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Coronary Artery Disease | DES

Korea, Republic of
Kyoto University, Graduate School of Medicine

Active, not recruiting

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study (STOPDAPT-3)

Acute Coronary Syndrome

Japan
HonorHealth Research Institute
Boston Scientific Corporation

Active, not recruiting

SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy (SYNIVUS-DAPT)

Coronary Artery Disease | Atherosclerosis | Stent Placement

United States
Seoul National University Hospital
B. Braun Korea Co., Ltd.

Completed

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial (HOST-IDEA)

Stable Angina | Unstable Angina | Non-ST Segment Elevation Myocardial Infarction

Korea, Republic of
Seoul National University Hospital

Active, not recruiting

Long Term Follow-up of Comparison of Clopidogrel vs. Aspirin Monotherapy After Drug-eluting Stent Implantation (HOST-EXAM-EX)

Coronary Artery Disease | Atheroscleroses, Coronary
Glaukos Corporation

Completed

Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents

Open-angle Glaucoma

Armenia
Shenyang Northern Hospital
Changhai Hospital; ANKON medical technologies (Shanghai)Co.,LTD

Completed

Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation (OPT-PEACE)

Ischemic Heart Disease | Gastrointestinal Injury

China
ECRI bv
AstraZeneca; The Medicines Company; Biosensors International

Completed

GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation

Coronary Artery Disease (CAD)

Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Portugal, Singapore, Spain, Switzerland, United Kingdom
ECRI bv
University of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaborators

Completed

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen (MASTER DAPT)

Coronary Artery Disease | PCI | High Bleeding Risk

Netherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
Seoul National University Hospital
Chong Kun Dang Pharmaceutical; Daewoong Pharmaceutical Co. LTD.; Hanmi Pharmaceutical... and other collaborators

Completed

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)

Coronary Heart Disease

Korea, Republic of
Beijing Anzhen Hospital

Enrolling by invitation

Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Drug-Eluting Stents

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Percutaneous Coronary Intervention | Drug-Eluting Stents

China
Beijing Anzhen Hospital
Beijing Friendship Hospital; The First Affiliated Hospital of Dalian Medical...

Unknown

The Success of Opening Concurrent CTO leSion to Improve Cardiac Function Trial in Patients With Multi-vessel Disease (SOS-moral)

Coronary Artery Disease | Percutaneous Coronary Intervention | Chronic Total Occlusion of Coronary Artery | Viable Myocardium

China
Ain Shams University

Completed

Endovascular Stenting of Medically Refractory ICASD (Clinical and Sonographic Study) (VasIntervent)

Stroke, Ischemic
University of Sharjah

Completed

Optimal Duration of Stretching Exercises for Chronic Non-specific Neck Pain Patients

Myofascial Pain Syndrome

United Arab Emirates
Euro CTO Club
NHS Research and Development; Biosensors International; Asahi Intecc Co., Ltd.

Completed

A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions (EuroCTO)

Coronary Occlusion | Dyspnea | Chronic Stable Angina

United Kingdom, Spain, France, Germany, Italy, Latvia
Yonsei University

Terminated

Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome

Acute Coronary Syndrome | Acute Myocardial Infarction | Unstable Angina (Intermediate Coronary Syndrome)

Korea, Republic of
Yonsei University

Terminated

Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery Disease

Coronary Artery Disease | Atrial Fibrillation

Korea, Republic of
Yonsei University

Completed

A Trial Comparing the Effect of Pravastatin and Rosuvastatin on Atherosclerosis Progression Measured by Carotid Intima Media Thickness in Patients With Coronary Artery Disease After Biolimus Eluting Stent (Nobori®) Implantation: CPR IMT

Coronary Artery Occlusive Disease

Korea, Republic of
Hospital de Meixoeiro

Completed

Platelet Reactivity After TAVI: A Multicenter Pilot Study (REAC-TAVI)

Transcatheter Aortic Valve Replacement | Transcatheter Aortic Valve Implantation | Severe Aortic Valve Stenosis

Spain
Boston Scientific Corporation

Completed

PROMUS Element Plus US Post-Approval Study

Coronary Artery Disease

United States
University of Pecs

Completed

Perioperative Evaluation of MMP-9-TIMP-1 System in Vascular Surgery Regarding Ischemic-reperfusion Injury

Ischemia Reperfusion Injury
The First Affiliated Hospital with Nanjing Medical...
National Natural Science Foundation of China

Completed

Pharmacogenetic and Pharmacokinetic Study of Clopidogrel (PPSC)

Coronary Artery Disease

China
Novartis Pharmaceuticals

Completed

Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers

Breast Cancer
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

Coronary Artery Disease

Korea, Republic of

Search clinical trials for: Optimal duration of clopidogrel post DES stent implantation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations